NBY effective against Monkeypox ! 20X Upside Analyst Rating!!!
NovaBay Pharmaceuticals, Inc. (NBY) owns Avenova, which is EPA listed as an effective disinfectant for monkeypox.
On 5/20/2022 Ascendiant Capital Markets brokerage set a price target of $4.00 for NovaBay Pharmaceuticals, Inc. (NBY).
The stock is now only 0.20usd.
Before the pandemic news, on their last earnings, they mentioned that Avenova Spray unit sales increased 15% with record-high units sold through the OTC channel.
NovaBay CEO: "we expect the majority of 2022 topline growth to come in the second half of this year."
The stock had only insider buys recently, the average being $0.45.
Only 10.976Mil MARKET CAP
The falling wedge in the chart is a bullish sign.
I think we can expect at least a reversal to the $0.64 resistance.
Looking forward to read your opinion about it.
On 5/20/2022 Ascendiant Capital Markets brokerage set a price target of $4.00 for NovaBay Pharmaceuticals, Inc. (NBY).
The stock is now only 0.20usd.
Before the pandemic news, on their last earnings, they mentioned that Avenova Spray unit sales increased 15% with record-high units sold through the OTC channel.
NovaBay CEO: "we expect the majority of 2022 topline growth to come in the second half of this year."
The stock had only insider buys recently, the average being $0.45.
Only 10.976Mil MARKET CAP
The falling wedge in the chart is a bullish sign.
I think we can expect at least a reversal to the $0.64 resistance.
Looking forward to read your opinion about it.
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals patreon.com/PremiumOptionsSignals
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
TRADING COURSE bit.ly/tradex
Private Signals patreon.com/PremiumOptionsSignals
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.